Donate
Research and discoveries
Study and careers
Industry partnerships
About us
Support us
Research and discoveries
Find a researcher
ICR divisions
Centres and strategic collaborations
Our facilities and technology
Research by cancer type
Cancer discovery news
Cancer blogs
Animal research
Our research achievements
ICR divisions
Breast Cancer Research
Cancer Biology
Cancer Therapeutics
Cell and Molecular Biology
Clinical Studies
Genetics and Epidemiology
Radiotherapy and Imaging
Structural Biology
Our facilities and technology
Baculovirus Facility
Light Microscopy Facility
Electron Microscopy Facility
Flow Cytometry Facility
Mechanical Workshop and 3D Printing
Proteomics Core Facility
Scientific Computing Service
Genomics Facility
X-ray Crystallography Facility
Chelsea Biophysics Facility
Correlative Light and Electron Microscopy (CLEM) Lab
Antibody Facility
Sutton Pathology Facility
Research by cancer type
Bladder cancer
Blood cancers
Bone cancer
Bowel cancer
Brain cancer
Breast cancer
Cervical cancer
Childhood cancers
Gastrointestinal cancers
Head and neck cancer
Kidney cancer
Lung cancer
Melanoma
Ovarian cancer
Pancreatic cancer
Prostate cancer
Sarcoma
Cancer blogs
Research blogs
The Darwin Cancer Blog
Our research achievements
Characterising the BRAF gene
Transforming prostate cancer treatment
Advanced radiotherapy techniques
Identifying a breast cancer gene
Targeting Hsp90
How cells become cancerous
The function of the thymus
Practice changing clinical trials in radiotherapy and imaging
DNA damage and cancer
Identifying cancer predisposition genes
Applying evolutionary biology to cancer
Transforming treatment for the most common type of breast cancer
Developing the Pharmacological Audit Trail
Discovering early chemotherapy drugs
Discovering and developing a leading PI3K inhibitor
Applying genetic principles to treatment of BRCA-mutant cancers
Carcinogens in cigarette smoke
Study and careers
PhDs for science graduates
Opportunities for clinicians
Student life and support
Undergraduate Summer Scholarship Scheme
Support moving to the UK
Careers at the ICR
Working life and benefits
PhDs for science graduates
Our PhD projects
Our PhD application process
Black Leaders in Cancer & Convergence PhD Studentships
PhD FAQs and funding
Contact student admissions
PhDs and training news
Opportunities for clinicians
MSc in Oncology
PhD and MD(Res) for clinicians
NIHR academic training
Radiotherapy and imaging training courses
Opportunities for postdoctoral clinical fellows
Student life and support
Tuition fees
Accommodation support
Welfare
Social life
Academic and career support
Student resources
Student stories
Alumni stories
Undergraduate Summer Scholarship Scheme
How to apply
FAQs
Research groups
Careers at the ICR
Postdocs
Research scientists and scientific support
Group leaders
Clinicians
Professional Service roles
Contact our career faculty
Apprenticeships
Working life and benefits
Staff benefits
World-leading working facilities
Equality and social groups
Career development
Employee stories
Industry partnerships
Partnership opportunities
Consultancy in oncology
Why partner with us
Our therapeutic pipeline
London Cancer Hub
Contact our partner team
Why partner with us
Our partnership philosophy
The Innovation Gateway
Entrepreneurs-in-residence
Spin-out companies
Enterprise events
Our treatment and technology successes
About us
Our strategy
Our history
Leadership and governance
ICR and The Royal Marsden
ICR news
Patient stories
Public engagement and schools outreach
Advocacy engagement: policy and public affairs
Funding and spending
Reports and policies
Contact us
Our strategy
Strategic partners
Our values
Equality and diversity
Sustainability
Leadership and governance
Our leadership team
Executive board
Board of trustees
Corporate governance
ICR committees
Public engagement and schools outreach
Resources for schools
Public engagement strategy
Public events
Our Engagement Stories
Advocacy engagement: policy and public affairs
Our policy priorities
Creating a sustainable funding model for research in universities
Encouraging international talent to support cancer research
Joining up the clinical research pipeline
Reports and policies
Annual reports
Improving access to clinical trials
Improving drug access
Use of biomarkers in cancer research and treatment
Freedom of speech
Annual report on bullying and harassment
Support us
Making a donation
Fundraising
Leave a legacy
Philanthropy
Corporate partnerships
Charity partners
Our appeals
Search newsletter
Making a donation
Why donate to the ICR
How is my money spent
Contact our donations team
Payroll giving
Gift Aid
Fundraising
How to fundraise with us
Sport events and challenges
Fundraising news
Supporter stories
Share your story
Volunteer at our events
Leave a legacy
Create a Will for free
Donate in memory
Information for executors
The National Free Wills Network
Meet our Legacy Marketing Officers
Philanthropy
Our philanthropic activity
Trusts and Foundations
Our appeals
Help every man with prostate cancer
Help us outsmart melanoma
Defeat blood cancer
Help more women survive cancer
Childhood cancers
Combination treatments
Monthly gift for cancer patients
Search:
Search
Research and discoveries
Study and careers
Industry partnerships
About us
Support us
See all hubs
Research and discoveries
Find a researcher
ICR divisions
Centres and strategic collaborations
Our facilities and technology
Research by cancer type
Cancer discovery news
Cancer blogs
Animal research
Our research achievements
See all hubs
Study and careers
PhDs for science graduates
Opportunities for clinicians
Student life and support
Undergraduate Summer Scholarship Scheme
Support moving to the UK
Careers at the ICR
Working life and benefits
See all hubs
Industry partnerships
Partnership opportunities
Consultancy in oncology
Why partner with us
Our therapeutic pipeline
London Cancer Hub
Contact our partner team
See all hubs
About us
Our strategy
Our history
Leadership and governance
ICR and The Royal Marsden
ICR news
Patient stories
Public engagement and schools outreach
Advocacy engagement: policy and public affairs
Funding and spending
Reports and policies
Contact us
See all hubs
Support us
Making a donation
Fundraising
Leave a legacy
Philanthropy
Corporate partnerships
Charity partners
Our appeals
Search newsletter
See Research and discoveries
Find a researcher
Publications
See Research and discoveries
ICR divisions
Breast Cancer Research
Cancer Biology
Cancer Therapeutics
Cell and Molecular Biology
Clinical Studies
Genetics and Epidemiology
Radiotherapy and Imaging
Structural Biology
See Research and discoveries
Our facilities and technology
Baculovirus Facility
Light Microscopy Facility
Electron Microscopy Facility
Flow Cytometry Facility
Mechanical Workshop and 3D Printing
Proteomics Core Facility
Scientific Computing Service
Genomics Facility
X-ray Crystallography Facility
Chelsea Biophysics Facility
Correlative Light and Electron Microscopy (CLEM) Lab
Antibody Facility
Sutton Pathology Facility
See Research and discoveries
Research by cancer type
Bladder cancer
Blood cancers
Bone cancer
Bowel cancer
Brain cancer
Breast cancer
Cervical cancer
Childhood cancers
Gastrointestinal cancers
Head and neck cancer
Kidney cancer
Lung cancer
Melanoma
Ovarian cancer
Pancreatic cancer
Prostate cancer
Sarcoma
See Research and discoveries
Cancer discovery news
Media office
See Research and discoveries
Cancer blogs
Research blogs
The Darwin Cancer Blog
See Research and discoveries
Our research achievements
Characterising the BRAF gene
Transforming prostate cancer treatment
Advanced radiotherapy techniques
Identifying a breast cancer gene
Targeting Hsp90
How cells become cancerous
The function of the thymus
Practice changing clinical trials in radiotherapy and imaging
DNA damage and cancer
Identifying cancer predisposition genes
Applying evolutionary biology to cancer
Transforming treatment for the most common type of breast cancer
Developing the Pharmacological Audit Trail
Discovering early chemotherapy drugs
Discovering and developing a leading PI3K inhibitor
Applying genetic principles to treatment of BRCA-mutant cancers
Carcinogens in cigarette smoke
See Study and careers
PhDs for science graduates
Our PhD projects
Our PhD application process
Black Leaders in Cancer & Convergence PhD Studentships
PhD FAQs and funding
Contact student admissions
PhDs and training news
See Study and careers
Opportunities for clinicians
MSc in Oncology
PhD and MD(Res) for clinicians
NIHR academic training
Radiotherapy and imaging training courses
Opportunities for postdoctoral clinical fellows
See Study and careers
Student life and support
Tuition fees
Accommodation support
Welfare
Social life
Academic and career support
Student resources
Student stories
Alumni stories
See Study and careers
Undergraduate Summer Scholarship Scheme
How to apply
FAQs
Research groups
See Study and careers
Careers at the ICR
Postdocs
Research scientists and scientific support
Group leaders
Clinicians
Professional Service roles
Contact our career faculty
Apprenticeships
See Study and careers
Working life and benefits
Staff benefits
World-leading working facilities
Equality and social groups
Career development
Employee stories
See Industry partnerships
Why partner with us
Our partnership philosophy
The Innovation Gateway
Entrepreneurs-in-residence
Spin-out companies
Enterprise events
Our treatment and technology successes
See Industry partnerships
Contact our partner team
Connections newsletter
See About us
Our strategy
Strategic partners
Our values
Equality and diversity
Sustainability
See About us
Leadership and governance
Our leadership team
Executive board
Board of trustees
Corporate governance
ICR committees
See About us
Public engagement and schools outreach
Resources for schools
Public engagement strategy
Public events
Our Engagement Stories
See About us
Advocacy engagement: policy and public affairs
Our policy priorities
Creating a sustainable funding model for research in universities
Encouraging international talent to support cancer research
Joining up the clinical research pipeline
See About us
Reports and policies
Annual reports
Improving access to clinical trials
Improving drug access
Use of biomarkers in cancer research and treatment
Freedom of speech
Annual report on bullying and harassment
See Support us
Making a donation
Why donate to the ICR
How is my money spent
Contact our donations team
Payroll giving
Gift Aid
See Support us
Fundraising
How to fundraise with us
Sport events and challenges
Fundraising news
Supporter stories
Share your story
Volunteer at our events
See Support us
Leave a legacy
Create a Will for free
Donate in memory
Information for executors
The National Free Wills Network
Meet our Legacy Marketing Officers
See Support us
Philanthropy
Our philanthropic activity
Trusts and Foundations
See Support us
Corporate partnerships
Corporate partnership highlights
See Support us
Our appeals
Help every man with prostate cancer
Help us outsmart melanoma
Defeat blood cancer
Help more women survive cancer
Childhood cancers
Combination treatments
Monthly gift for cancer patients
Dr
Renee
Flaherty
Honorary Appointment:
Endocrine Control Mechanisms
Phone:
+44 20 7153 5392
Email:
[email protected]
Location: Chelsea
Phone:
+44 20 7153 5392
Email:
[email protected]
Location: Chelsea
Home
Research and discoveries
Find a researcher
Related pages
Endocrine Control Mechanisms
Breast Cancer Research
